EMAIL THIS PAGE TO A FRIEND

The Journal of arthroplasty

Topical administration of tranexamic acid in primary total hip and total knee arthroplasty.


PMID 24238825

Abstract

Major blood loss is a known potential complication in total hip and total knee arthroplasty. We conducted a prospective, stratified, randomized, double-blind, placebo-controlled trial that evaluated 100 patients undergoing total knee or total hip arthroplasty to evaluate the effect on blood loss using the topical application of tranexamic acid. Participants received either 2 g of topical tranexamic acid or the equivalent volume of placebo into the joint prior to surgical closure. Tranexamic acid resulted in a lower mean maximum decline in postoperative hemoglobin levels when compared to placebo (P = 0.013). Patients in the tranexamic acid group demonstrated an improved but non-significant reduction in the units of blood transfused compared to placebo (P = 0.423). There was no clinically significant increase in complications in the tranexamic acid group, including no incidence of venous thromboembolism.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

1672745
Tranexamic acid, United States Pharmacopeia (USP) Reference Standard
C8H15NO2